ADMA Biologics, Inc. (ADMA) Ownership

$19.13

north_east
$0.69 (3.74%)
Day's range
$18.5
Day's range
$19.2

ADMA Biologics, Inc. Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
BLACKROCK FUNDING, INC. /DE 02/07/2025 38.15 M $654.27 M   -0.31% 16.26%
VANGUARD GROUP INC 02/11/2025 18.20 M $312.11 M   0.44% 7.76%
STATE STREET CORP 02/14/2025 14.87 M $255.03 M   14.35% 6.34%
INVESCO LTD. 02/13/2025 11.30 M $193.73 M   -10.49% 4.82%
GEODE CAPITAL MANAGEMENT, LLC 02/12/2025 5.43 M $93.19 M   0.94% 2.32%
DIMENSIONAL FUND ADVISORS LP 02/13/2025 4.67 M $80.07 M   15.99% 1.99%
NUVEEN ASSET MANAGEMENT, LLC 02/14/2025 4.55 M $78.07 M   -30.79% 1.94%
DEUTSCHE BANK AG\ 02/14/2025 3.88 M $66.47 M   -6.20% 1.65%
AMERICAN CENTURY COMPANIES INC 02/11/2025 3.77 M $64.72 M   -10.36% 1.61%
RENAISSANCE TECHNOLOGIES LLC 02/13/2025 3.77 M $64.65 M   2.80% 1.61%
PERPETUAL LTD 01/17/2025 3.63 M $62.30 M   100.00% 1.55%
OBERWEIS ASSET MANAGEMENT INC/ 02/14/2025 3.34 M $57.32 M   14.98% 1.43%
FMR LLC 02/13/2025 3.20 M $54.84 M   64.42% 1.36%
D. E. SHAW & CO., INC. 02/14/2025 3.07 M $52.59 M   -41.75% 1.31%
TWO SIGMA ADVISERS, LP 02/14/2025 2.95 M $50.59 M   -33.77% 1.26%
ALLSPRING GLOBAL INVESTMENTS HOLDINGS, LLC 01/29/2025 2.84 M $51.02 M   1,144.42% 1.21%
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP 02/12/2025 2.76 M $47.38 M   57.94% 1.18%
GOLDMAN SACHS GROUP INC 02/11/2025 2.70 M $46.28 M   3.33% 1.15%
TWO SIGMA INVESTMENTS, LP 02/14/2025 2.55 M $43.71 M   -29.03% 1.09%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 02/06/2025 2.44 M $41.85 M   1.61% 1.04%
AWM INVESTMENT COMPANY, INC. 02/18/2025 2.43 M $41.61 M   -45.51% 1.03%
02/14/2025 2.29 M $39.23 M   100.00% 0.98%
LORD, ABBETT & CO. LLC 02/14/2025 2.21 M $37.86 M   -28.67% 0.94%
PRICE T ROWE ASSOCIATES INC /MD/ 02/14/2025 2.10 M $36.03 M   0.02% 0.90%
BANK OF NEW YORK MELLON CORP 02/04/2025 1.52 M $26.09 M   10.76% 0.65%
ALTIUM CAPITAL MANAGEMENT LP 02/13/2025 1.40 M $23.92 M   2.57% 0.59%
DRIEHAUS CAPITAL MANAGEMENT LLC 02/14/2025 1.37 M $23.52 M   -33.30% 0.58%
OPHIR ASSET MANAGEMENT PTY LTD 02/14/2025 1.34 M $23.01 M   75.84% 0.57%
FEDERATED HERMES, INC. 02/13/2025 1.31 M $22.41 M   -19.71% 0.56%
PRINCIPAL FINANCIAL GROUP INC 01/31/2025 1.26 M $21.59 M   5.43% 0.54%
STONEPINE CAPITAL MANAGEMENT, LLC 02/14/2025 1.24 M $21.28 M   -33.63% 0.53%
MILLENNIUM MANAGEMENT LLC 02/14/2025 1.16 M $19.89 M   3.81% 0.49%
RAYMOND JAMES FINANCIAL INC 02/13/2025 1.11 M $19.08 M   100.00% 0.47%
MACQUARIE GROUP LTD 02/14/2025 1.01 M $17.40 M   -10.86% 0.43%
UBS GROUP AG 02/14/2025 1.00 M $17.22 M   140.34% 0.43%
CITIGROUP INC 02/12/2025 942,183 $16.16 M   143.32% 0.40%
VOYA INVESTMENT MANAGEMENT LLC 02/14/2025 918,361 $15.75 M   46.77% 0.39%
PERCEPTIVE ADVISORS LLC 02/14/2025 890,280 $15.27 M   -16.03% 0.38%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 02/14/2025 881,000 $15.11 M   55.27% 0.38%
LEGAL & GENERAL GROUP PLC 02/13/2025 836,850 $14.35 M   20.06% 0.36%
MESIROW INSTITUTIONAL INVESTMENT MANAGEMENT, INC. 02/13/2025 782,451 $13.42 M   -21.90% 0.33%
JPMORGAN CHASE & CO 02/12/2025 767,265 $13.16 M   272.54% 0.33%
MAN GROUP PLC 02/14/2025 745,300 $12.78 M   305.51% 0.32%
AMERIPRISE FINANCIAL INC 02/14/2025 715,672 $12.27 M   14.12% 0.31%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 02/14/2025 686,900 $11.78 M   1,486.37% 0.29%
FIRST TURN MANAGEMENT, LLC 02/14/2025 684,230 $11.73 M   2.89% 0.29%
RUSSELL INVESTMENTS GROUP, LTD. 02/13/2025 646,009 $11.08 M   -20.05% 0.28%
RHUMBLINE ADVISERS 01/30/2025 621,079 $10.65 M   0.96% 0.26%
QUBE RESEARCH & TECHNOLOGIES LTD 02/14/2025 602,767 $10.34 M   95.65% 0.26%
ASSENAGON ASSET MANAGEMENT S.A. 01/14/2025 591,679 $10.15 M   -82.97% 0.25%

ADMA Biologics, Inc. institutional Ownership - FAQ's

During the previous two years, 391 institutional investors and hedge funds held shares of ADMA Biologics, Inc.. The most heavily invested institutionals were:

BlackRock Funding, Inc. /DE: 38.15 M

VANGUARD GROUP INC: 18.2 M

STATE STREET CORP: 14.87 M

Invesco Ltd.: 11.3 M

GEODE CAPITAL MANAGEMENT, LLC: 5.43 M

DIMENSIONAL FUND ADVISORS LP: 4.67 M

86.90% of ADMA Biologics, Inc. stock is owned by institutional investors.

Institutional investors have bought a total of 229.94 M shares in the last 24 months. This purchase volume represents approximately $4.40 B in transactions.